21-hydroxylase deficiency ultrasound: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Aditya Ganti (talk | contribs) |
||
| Line 23: | Line 23: | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Radiology]] | [[Category:Radiology]] | ||
Latest revision as of 15:33, 24 July 2020
|
21-hydroxylase deficiency Microchapters |
|
Differentiating 21-Hydroxylase Deficiency from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency ultrasound On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency ultrasound |
|
Risk calculators and risk factors for 21-hydroxylase deficiency ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
On ultrasound, 21-hydroxylase deficiency is characterized by enlarged, wrinkled, and cerebriform adrenal glands. Testicular masses may be seen in the setting of classical disease.
Ultrasound Findings in 21-hydroxylase deficiency
Ultrasound findings in patients with 21 hydroxylase deficiency are:[1][2]
- Enlarged adrenal glands
- Wrinkled surface of adrenal glands
- Cerebriform pattern of adrenal glands (pathognomonic sign)
- Normal ultrasound appearances may also be seen
- Testicular masses may be identified representing adrenal rest tissue
References
- ↑ Congenital adrenal hyperplasia. Dr Henry Knipe and Dr M Venkatesh . Radiopaedia.org 2015.http://radiopaedia.org/articles/congenital-adrenal-hyperplasia
- ↑ Teixeira SR, Elias PC, Andrade MT, Melo AF, Elias Junior J (2014). "The role of imaging in congenital adrenal hyperplasia". Arq Bras Endocrinol Metabol. 58 (7): 701–8. PMID 25372578.